He has been member and chair of several research oversight committees, for both trial steering and data monitoring, at national and international levels relating to quality and conduct standards of clinical trials (including trials conducted by UK NIHR and WHO). These have been published successfully on completion.
In leadership positions such as Clinical Director, Research and Development, Barts Health NHS Trust (2014-17), and Director, Research and Development Birmingham Women’s Hospital (2006-10), in the UK, he has had the responsibility of providing a regulatory framework and oversight for trials and clinical studies. In this role he has undertaken investigations of allegations of scientific misconduct among studies in progress.
He has also been involved in independent investigation of alleged scientific misconduct. In addition, as former Chief Editor, he has investigated several allegations of research misconduct among completed studies submitted for publication or post-publication.